Point72 Asset Management’s Wells Fargo WFC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22M Buy
276,200
+18,400
+7% +$1.58M 0.03% 755
2025
Q4
$24M Buy
257,800
+39,400
+18% +$3.42M 0.03% 778
2025
Q3
$18.3M Buy
218,400
+211,200
+2,933% +$17.1M 0.03% 586
2025
Q2
$577K Sell
7,200
-25,300
-78% -$1.82M ﹤0.01% 1739
2025
Q1
$2.33M Buy
32,500
+9,800
+43% +$736K 0.01% 1199
2024
Q4
$1.59M Sell
22,700
-343,200
-94% -$23.4M ﹤0.01% 1325
2024
Q3
$20.7M Buy
365,900
+189,700
+108% +$10.7M 0.05% 411
2024
Q2
$10.5M Sell
176,200
-41,100
-19% -$2.43M 0.03% 600
2024
Q1
$12.6M Buy
217,300
+152,500
+235% +$7.98M 0.03% 628
2023
Q4
$3.19M Sell
64,800
-124,200
-66% -$5.36M 0.01% 1067
2023
Q3
$7.72M Buy
+189,000
New +$8.16M 0.02% 740
2023
Q2
Sell
-58,800
Closed -$2.2M 2842
2023
Q1
$2.2M Sell
58,800
-136,200
-70% -$5.94M 0.01% 958
2022
Q4
$8.05M Buy
195,000
+64,400
+49% +$2.85M 0.03% 617
2022
Q3
$5.25M Buy
+130,600
New +$5.61M 0.02% 712
2018
Q4
Sell
-263,500
Closed -$13.8M 1234
2018
Q3
$13.8M Buy
+263,500
New +$15M 0.06% 388

Other funds holding WFC

Point72 Asset Management's WFC Position: Q4 2025 in Review

Point72 Asset Management sold out of Wells Fargo (WFC) in Q4 2025, closing a stake of 185,830 shares — an estimated $16.1M sold.

Point72 Asset Management first reported a position in WFC in Q3 2016 and held it in 21 quarters. The position peaked at $142M in Q1 2025. 2,896 funds tracked by Wall St. Rank hold WFC as of Q4 2025.

  • Point72 Asset Management reported no remaining Wells Fargo position as of Q4 2025 after selling out during the quarter.
  • Point72 Asset Management sold 185,830 Wells Fargo shares in Q4 2025, an estimated $16.1M.
  • Point72 Asset Management first reported a position in Wells Fargo in Q3 2016 and held it in 21 quarters.
  • Point72 Asset Management's Wells Fargo position peaked at $142M in Q1 2025.
  • 2,896 funds tracked by Wall St. Rank held Wells Fargo as of Q4 2025.

Based on Point72 Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.